Savient expands board of directors

EAST BRUNSWICK, N.J. — A specialty biopharmaceutical company has elected two members to its board of directors.

Savient said that William Owen, current president of the University of Medicine & Dentistry of New Jersey, and David Norton, the former company group chairman of global pharmaceuticals for Johnson & Johnson, were elected Sept. 1.

"We believe that Bill and David bring unique and relevant experience to our board of directors that will complement and be immediately beneficial to our board and senior management team," Savient board chairman Stephen Jaeger said.